Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

258 ARTÍCULOS , VIENDO DEL 181 AL 195

Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature

Chen JJ, Ondo WG, Dashtipour K, Swope DM.

Clin Ther. 2012 Jul;34(7):1487-504. doi: 10.1016/j.clinthera.2012.06.010. Epub 2012 Jun 28.

The representation of movement disorders in fictional literature

Voss H.

J Neurol Neurosurg Psychiatry. 2012 Oct;83(10):994-9. doi: 10.1136/jnnp-2012-302716. Epub 2012 Jun 29.

Genetics of Parkinson disease and other movement disorders

Kumar KR, Lohmann K, Klein C.

Curr Opin Neurol. 2012 Aug;25(4):466-74. doi: 10.1097/WCO.0b013e3283547627.

Phenotypes and genetic architecture of focal primary torsion dystonia

Groen JL, Kallen MC, van de Warrenburg BP, Speelman JD, van Hilten JJ, Aramideh M, Boon AJ, Klein C, Koelman JH, Langeveld TP, Baas F, Tijssen MA.

J Neurol Neurosurg Psychiatry. 2012 Oct;83(10):1006-11. doi: 10.1136/jnnp-2012-302729. Epub 2012 Jul 8.

Reversible generalized dystonia and encephalopathy from thiamine transporter 2 deficiency

Serrano M, Rebollo M, Depienne C, Rastetter A, Fernández-Álvarez E, Muchart J, Martorell L, Artuch R, Obeso JA, Pérez-Dueñas B.

Mov Disord. 2012 Sep 1;27(10):1295-8. doi: 10.1002/mds.25008. Epub 2012 Jul 6.

[Deep brain stimulation for movement disorders]

Steigerwald F, Volkmann J.

Nervenarzt. 2012 Aug;83(8):988-93. doi: 10.1007/s00115-012-3570-1.

Pediatric indications for deep brain stimulation

DiFrancesco MF, Halpern CH, Hurtig HH, Baltuch GH, Heuer GG.

Childs Nerv Syst. 2012 Oct;28(10):1701-14. doi: 10.1007/s00381-012-1861-2. Epub 2012 Jul 25.

Benign hereditary chorea: phenotype, prognosis, therapeutic outcome and long term follow-up in a large series with new mutations in the TITF1/NKX2-1 gene

Gras D, Jonard L, Roze E, Chantot-Bastaraud S, Koht J, Motte J, Rodriguez D, Louha M, Caubel I, Kemlin I, Lion-François L, Goizet C, Guillot L, Moutard ML, Epaud R, Héron B, Charles P, Tallot M, Camuzat A, Durr A, Polak M, Devos D, Sanlaville D, Vuillaume I, Billette de Villemeur T, Vidailhet M, Doummar D.

J Neurol Neurosurg Psychiatry. 2012 Oct;83(10):956-62. doi: 10.1136/jnnp-2012-302505. Epub 2012 Jul 24.

THAP1 mutations and dystonia phenotypes: genotype phenotype correlations

Xiromerisiou G, Houlden H, Scarmeas N, Stamelou M, Kara E, Hardy J, Lees AJ, Korlipara P, Limousin P, Paudel R, Hadjigeorgiou GM, Bhatia KP.

Mov Disord. 2012 Sep 1;27(10):1290-4. doi: 10.1002/mds.25146. Epub 2012 Aug 17.

[Consensus conference of the Mexican Association for the Study of Climateric on veralipride prescription for patients with vasomotor symptoms]

Basavilvazo-Rodríguez A, Bravo-Rodríguez LM, Carranza-Lira S, Celis-González C, Hernández Marín I, Hernández-Valencia M, López Navarro ME, Alvarado Maldonado Jde D, Armando Montaño J, Moreno Avellán AJ, Vázquez G.

Ginecol Obstet Mex. 2012 Jul;80(7):467-72.

Dystonia with brain manganese accumulation resulting from SLC30A10 mutations: a new treatable disorder

Stamelou M, Tuschl K, Chong WK, Burroughs AK, Mills PB, Bhatia KP, Clayton PT.

Mov Disord. 2012 Sep 1;27(10):1317-22. doi: 10.1002/mds.25138. Epub 2012 Aug 23.

Sensory trick with metoclopramide-associated tardive tremor

Shprecher D.

BMJ Case Rep. 2012 Sep 7;2012:bcr1120115156. doi: 10.1136/bcr-11-2011-5156.

Clinical features and treatment with botulinum toxin in blepharospasm: a 17-year experience

Aquino CC, Felício AC, Castro PC, Oliveira RA, Silva SM, Borges V, Ferraz HB.

Arq Neuropsiquiatr. 2012 Sep;70(9):662-6. doi: 10.1590/s0004-282x2012000900003.

Substance of abuse and movement disorders: complex interactions and comorbidities

Deik A, Saunders-Pullman R, Luciano MS.

Curr Drug Abuse Rev. 2012 Sep;5(3):243-53. doi: 10.2174/1874473711205030243.

Movement disorders and sleep

Driver-Dunckley ED, Adler CH.

Neurol Clin. 2012 Nov;30(4):1345-58. doi: 10.1016/j.ncl.2012.08.019.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias